期刊文献+

血液透析患者血清脂蛋白(a)与炎症、氧化应激关系研究 被引量:1

The association of serum in hemodialysis patients levels and inflammation and oxidative stress in hemodi-alysis patients
下载PDF
导出
摘要 目的探讨血液透析患者脂蛋白(a)[Lp(a)]代谢紊乱机制,为寻找有效控制Lp(a)紊乱的方法提供理论基础。方法收集53例透析患者、42例体检健康者空腹血清,AEROSET-2000全自动生化分析仪测定血清Lp(a)。酶联免疫吸附法(ELISA)检测氧化低密度脂蛋白(ox-LDL)、白介素-1β(IL-1β)、白介素-6(IL-6)、白介素-8(IL-8)、肿瘤坏死因子-α(TNF-α)。结果透析组血清Lp(a)水平均显著高于对照组;透析组血清炎症相关因子IL-6、IL-8、TNF-α均显著高于对照组,IL-1β水平无显著性差异;相关性分析显示IL-6、IL-8与Lp(a)水平显著正相关。透析患者血清ox-LDL含量与对照组比差异显著,且与Lp(a)呈非常显著正相关(P<0.01)。结论透析患者处于炎症、氧化应激状态可能是Lp(a)代谢紊乱且不易控制的原因之一。 Objective To clarify the mechanism of high levelin hemodialysis patients Lp (a) in hemodialysis patients. Methods The study was conducted on a sample of 53 chronic renal failure patients (males: 37, females: 16, age 23-75 years) who had receired hemodialysis treatment above one year. Fourty-two samples from healthy physical examination were as controls. Lp(a) level were detected by AEROSET-2000 biochemistry auto-analyzer. The quantifications of 0x-LDL, IL-l beta, IL-6, IL-8 and TNF-alpha were performed with double-antibody ELISA. Results The serum Lp(a) levels were remarkably higher in CRF patients than in the control subjects (P〈0.05). The serum ox-LDL IL-6 and IL-8, TNF- α levels in hemodialysis patients were remarkably higher than in the control subjects, but there were no significant difference of IL-1 β level between the two groups. There were significant correlations between Lp(a) and IL-6, IL-8 and ox-LDL. Conclusions Lp(a) has comelation with inflammation and oxidative stress. It maybe one of the reasons of in creased and disordered Lp(a) level in hemodialysis patients.
出处 《中国血液净化》 2006年第9期661-662,共2页 Chinese Journal of Blood Purification
基金 辽宁省自然科学基金资助(编号:20042055)
关键词 脂蛋白(a) 血液透析 炎症因子 氧化低密度脂蚩白 Hemodialysis: Lipoprotein (a) Ox-LDL Cytokine
  • 相关文献

参考文献9

  • 1Navarro J F,Mora C,Muros M,et al.Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.Nephron Clin Pract,2003,95(4):128-135.
  • 2Diaz Peromingo J A,Carbajal D G,Alban-Salgado A.Lipoprotein a in patients on hemodialysis.Acta-Med-Austriaca,2004,31(3):73-75.
  • 3郭彦聪,张凌.低分子肝素对血液透析患者脂代谢影响的回顾性分析[J].中国血液净化,2003,2(6):311-314. 被引量:11
  • 4赵轶雯,王质刚.维生素E修饰的透析膜对血液透析患者血脂的影响[J].中国血液净化,2004,3(6):313-315. 被引量:8
  • 5Sophie Gonbert,Sophie Malnsky,Andrei C.Sposito,et al.Atorvastatin lowers lipoproteina but not apolipoprotein afragment levels in hypercholesterolemic subjects at highcardiovascular risk.Atherosclerosis,2002,164:305-311.
  • 6李新,彭立人.血液透析患者血清IL-6与急性时相反应的关系研究[J].中国血液净化,2004,3(7):371-373. 被引量:12
  • 7Nguyen-Khoa T,Massy Z A,De Bandt J P,et al.Oxidative stress and haemodialysis:Role of inflammation and dura tion of dialysis treatment.Nephrol Dial Transplant,2001,16 (2):335-340.
  • 8Kunsch C,Medford RM.Oxidative stress as a regulator of gene expression in the vasculature.Circ Res,1999,85(8):753-766.
  • 9Emanuele E,Lusignani L S,Peros E,et al.Lipoproteinaassociated atherothrombotic risk in hemodialysis patients.Am J Nephrol,2004,24(2):221-229.

二级参考文献32

  • 1[1]Arnadottir M,Kurkus J,Nilsson EP. Different types of heparin in hemeodialysis: long term effects on post-heparin lipases. Scard J Clin Lab Invest,1994,54:515-521
  • 2[2]Bergvist D.Low molecular weight heparins.J Intern Med ,1996,240:63-72
  • 3[3]Stefoni S, Cianciolo G, Donati G et al. Standard heparin versus low-molecular-weight heparin. A medium-term comparison in hemodialysis. Nephron, 2002,92(3):589-600
  • 4[4]Lai KN, Ho K, Cheung RC et al. Effect of low molecular weight heparin on bone metabolism and hyperlipidemia in patients on maintenance hemodialysis. Int J Artif Organs, 2001, 24(7):447-55
  • 5[5]Stenvinkel P.Low molecular weight heparin:Does it favourably affect lipid levels?Nephrol Dial Transplant,1995,19:16
  • 6[6]Weintraub M,Rassin T,Eisenberg S, et al.Continuous intravenous heparin administration in humans causes a decrease in serum lipolytic activity and accumulation of chylomicrons in circulation.J Lipid Res,1994,35:229
  • 7[7]Yang C,Wu T,Huang C,et al.Low molecular weight heparin reduces triglyceride,VLDL and cholesterol/HDL levels in hyperlipidemic diabetic patients on hemodialysis.Am J Nephrol,1998,18(5):384
  • 8[8]Elisaf MS,Germanos NP,Bairaktari HT,et al.Effects of conventional vs low-molecularweight heparin on lipid profil in hemodialysis patients.Am J Nephrol,1997,17(2):153
  • 9[9]Kronenberg F,Konig P,Neyer U,et al.Influence of various heparin preparation on lipoproteins in hemodialysis patients:a multicentre study.Thromb Haemost,1995,74(4):1025
  • 10[10]Kronenberg F,Konig Pm,Lhotta K,et al.Low molecular weight heparin does not necessarily reduce lipids and lipoproteins in hemodialysis patients.Clin Nephrol,1995,43:399

共引文献28

同被引文献9

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部